World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT01075594
Date of registration: 19/02/2010
Prospective Registration: No
Primary sponsor: AstraZeneca
Public title: Study of Undertreatment of Patients With Dyslipidemia in Bulgaria CEPHEUS
Scientific title: Centralized Pan-Bulgarian Survey on the Undertreatment of Hypercholesterolemia
Date of first enrolment: February 2010
Target sample size: 2500
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT01075594
Study type:  Observational
Study design:  Time Perspective: Prospective  
Phase:  N/A
Countries of recruitment
Bulgaria
Contacts
Key inclusion & exclusion criteria

Inclusion Criteria:

- Lipid lowering drug treatment for at least 3 months, with no dose change for a
minimum of 6 weeks

- Signed Informed Consent

Exclusion Criteria:

- Informed Consent not provided



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Dyslipidemia
Intervention(s)
Primary Outcome(s)
The number and percentage of patients achieving the LDL-C goals, according to the Fourth Joint European Task Force guidelines [Time Frame: 6 months - one visit only, no follow-up visits]
Secondary Outcome(s)
The number and percentage of subjects achieving the LDL-C goals, according to the Fourth Joint European Task Force guidelines for several subject subsets [Time Frame: 6 months - one visit only, no follow-up visits]
The number and percentage of subjects achieving the non HDL-C goals according to the NCEP ATP III/updated 2004 NCEP ATP III/national guidelines [<130mg/dL (3,37mmol/L)], in the following sub-population: patients with fasting triglycerides >200 mg/dL [Time Frame: 6 months - one visit only, no follow-up visits]
The number and percentage of subjects achieving LDL-C goals according to the NCEP ATP III / 2004 updated 2004 NCEP ATP III guidelines, overall and for several subject subsets [Time Frame: 6 months - one visit only, no follow-up visits]
Secondary ID(s)
NIS-CBG-CRE-2009/1
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history